期刊文献+

三氧化二砷对人视网膜母细胞瘤SO-Rb50瘤细胞成瘤性研究 被引量:1

Effects of arsenic trioxide(ATO )on tumorigenicity of human retinoblastoma cells SO-RB50
原文传递
导出
摘要 目的了解三氧化二砷(arsenic trioxide,ATO)对人视网膜母细胞瘤SO—Rb50瘤细胞株成瘤性的影响。方法取出生14d的SD大鼠10只,用含24μmol/l三氧化二砷的5×10^7m1 SO—Rb50瘤细胞悬液0.03ml注射到大鼠任一眼前房;另一眼前房注射同量不含三氧化二砷的瘤细胞悬液作为对照,每日裂隙灯观察前房肿瘤形成的情况;接种后20d,按照接种液是否含有三氧化二砷分为两组,分别挖出荷瘤大鼠眼内的肿瘤组织测定谷胱苷肽过氧化物酶活性;通过统计学分析两组前房肿瘤形成的情况及肿瘤组织谷胱苷肽过氧化物酶活性的差异。结果含24μmol/l三氧化二砷的瘤细胞悬液注射前房后成瘤时间平均为6日(对照组为[日),明显延长(t=7.21,P〈0.01),肿瘤性新生血管形成时间平均为13.8日(对照组为9.6日),也明显延长(t=9.35,P〈0.01);肿瘤组织的谷胱苷肽过氧化物酶活性A340均值为0.144(对照组均值为0.135),活性明显增强(t=9.74,P〈0.01)。结论24μmol/l三氧化二砷能够显著延长SO-Rb50瘤细胞悬液注射前房后成瘤的时间及肿瘤性新生血管形成时间,形成的瘤组织谷胱苷肽过氧化物酶活性明显增强。 Objective To investigate the effect of arsenic trioxide (ATO) on the tumorigenicity of human retinoblastoma cells SO-Rb50. Methods Ten 14-days old SD rats were used in this study. The 0.03ml of 5×105/ml SO-Rb50 cells with 24p mol/l ATO were injected into one anterior chamber of the eye, as the contrast, the opposite eye was injected into the same quantity cells only, then the tumor formation in the anterior chamber of those rats were observed by the slit lamp. After implanted 20 days, the tumor tissues were removed and divided into two groups according to whether containing ATO in the inoculation liquid. The Glutathione peroxidase activity was examined and statistical analysis was performed.Results The tumors and the new vessels of the ones received SO-Rb50 cells with 24p mol/1 ATO injected into anterior chamber had formed in average 6 days and 13.8 days respectively, both of which were longer than that of tumor cells injection only group, which were 2 days ( t=-7.21, P〈0.01 ) and 9.6 days (t=-9.35, P〈0.01 ) respectively. The Glutathione peroxidase activity of the A340 of the tumor tissues was 0.144, which was stronger than the contrast of 0.135 (t=-9.74, P〈0.01 ).Conclusions 24p mol/l ATO can prolonged tumor and tumorous new vessels formation time of SO-Rb50 cells injected into the rats' anterior chambers effectively, and increase the Glutathione peroxidase activity of the tumor tissues.
作者 唐松 应方微
出处 《中国实用眼科杂志》 CSCD 北大核心 2010年第1期90-92,共3页 Chinese Journal of Practical Ophthalmology
基金 深圳市科技局项目(200603160)
关键词 视网膜母细胞瘤 三氧化二砷 大鼠 Retinoblastoma Arsenic trioxide (ATO) Rat
  • 相关文献

参考文献9

  • 1唐松,李永平,应方微,李永强,冯官光,易玉珍.视网膜母细胞瘤抗原致敏的树突状细胞疫苗抗SO-RB_(50)细胞系的实验研究[J].中华眼科杂志,2004,40(4):229-233. 被引量:7
  • 2Oketani M,Kohara K,Tuvdendorj D,et al.Inhibition by arsenic trioxide of human hepatoma cell growth[J].Cancer Lett,2002,183(2):147-53.
  • 3Pelicano H,Feng L,Zhou Y,et al.Inhibition of mitochondrial respiration:a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism[J].Biol Chem,2003 Sep 26,278(39):37832-9.Epub 2003 Jul 9.
  • 4应方微,李永平,唐松,钟秀风,林健贤,郑健樑,潘苏华,易玉珍.抗视网膜母细胞瘤细胞株SO-Rb_(50)单克隆抗体相应抗原的提取[J].中华眼底病杂志,2003,19(3):152-155. 被引量:5
  • 5Meadows AT,Leahey AM.More about second cancers after retinoblastoma[J].Natl Cancer Inst,2008,100(24):1743-5.
  • 6陈伟,黄沛力.三氧化二砷诱导肿瘤细胞凋亡机制的研究进展[J].毒理学杂志,2005,19(1):52-54. 被引量:5
  • 7Mervis J.Ancient remedy performs new tricks[J].Science,1996,273(5275):578.
  • 8Baysan A,Yel L,Gollapudi S,Su H,et al.Arsenic trioxide induces apoptosis via the mitochondrial pathway by upregulating the expression of Bax and Bim in human B cells[J].Int J Oncol,2007 Feb,30(2):313-8.
  • 9Izdebska M,Grzanka A,Szczepa n ski M.A,et al.[Selected mechanisms of the therapeutic effect of arsenic trioxide in cancer treatment.Postepy Hig Med Dosw,2008 Sep 9,62:463-7[J].

二级参考文献36

  • 1Baoxiang Qu~1 , Zilan Zhuo~1 Yuzhen Yi~2 , Guanguang Feng~2 , Jianliang Zheng~2,Qiwan Liang~1 , Yongping Li~2 1 Cancer center, Sun Yat-Sen University of medical Sciences Guangzhou 510060, China 2 Zhongshan Ophthalmic Center, Sun Yat-Sen University of Medical Sciences Guangzhou 510060, China.Dynamic Investigation on Chromosome Aberration of a Human Retinoblastoma Cell Line SO-Rb_(50)[J].眼科学报,1993,9(1):38-39. 被引量:2
  • 2冯官光,李永平,易玉珍,郑健梁,郑湖铃,林健贤.视网膜母细胞瘤细胞系裸小鼠异种移植瘤实验研究[J].中华眼科杂志,1994,30(1):47-49. 被引量:22
  • 3李永平,冯官光,曹弃元,易玉珍,李永强,李亮平,郑健梁.LAK细胞体外未能杀伤视网膜母细胞瘤细胞株[J].癌症,1997,16(1):65-66. 被引量:2
  • 4李永平,冯官光,宁波,易玉珍,张平,谢楚芳,郑健梁,黄祥坤.抗视网膜母细胞瘤瘤细胞单克隆抗体的研制[J].中华眼底病杂志,1997,13(1):3-5. 被引量:5
  • 5Ian H,Camilo C.Fusion induces tumor rejection.Nature,1997,388:626-627.
  • 6Banchereau J,Steinman RM.Dendritic cells and the control of immunity.Nature,1998,392:245-252.
  • 7Romani N,Gumer S, Brang G,et al.Proliferating dendritic cell progenitors in human blood. J Exp Med, 1994,180:83-93.
  • 8Sang DN,Albert DM.Retinoblastoma: clinical and histopathologic features.Hum Pathol, 1982,13: 133-147.
  • 9Hernando J,Kende AS,Milbank JB,et al.Vaccination with autologous tumor antigen-pulsed dendritic cells in advanced gynaecological maligancies:clinical and immunological evaluation of a phase Ⅰ trial.Cancer Immunol Immunother,2002,51:45-52.
  • 10Steinman RM,Dhodapkar M.Active immunization against cancer with dendritic cells:the near future.Int J Cancer,2001,94:459-473.

共引文献14

同被引文献7

  • 1白大勇,史季桐,赵军阳,于刚.视网膜母细胞瘤的激光治疗[J].国际眼科纵览,2007,31(4):282-285. 被引量:3
  • 2Shields CL, Shields JA. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy [ J ]. Curr Opin Ophthalmol, 2010,21(3) :203 -212.
  • 3Linn Murphree A. Intraocular retinoblastoma:the case for a new group classification [ J ]. Ophthalmol Clin North Am,2005,18( 1 ) :41 -53.
  • 4Chart HS, DeBoer G, Thiessen JJ, et al. Combining cyclosporin with chemotherapy controls intraocular retino-blastoma without requiring radiation [ J ]. Clin Cancer Res, 1996,2(9) : 1499 - 1508.
  • 5Zhao J, Dimaras H, Massey C, et al. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis [ J ]. J Clin Oncol,2011,29 ( 7 ) : 845 - 851.
  • 6赵军阳.从R-E到IRC分级:视网膜母细胞瘤治疗观念的转变[J].眼科,2007,16(6):368-372. 被引量:17
  • 7郁想想,陈长征,赵军阳,郑红梅,叶美红,李璐,武犁.视网膜母细胞瘤综合治疗疗效分析[J].武汉大学学报(医学版),2012,33(2):247-250. 被引量:7

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部